Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary
May 5, 2022
Earnings Call Speaker Segments
Victor Falvo
executiveThanks, operator, and thanks to all of you for joining us on Chimera's conference call about our first quarter 2022 earnings. Prior to getting started, I want to go over the safe harbor statements. On this call, forward-looking statements will be made, meaning predictions, projections, or other statements regarding future events. Current expectations and assumptions form the basis for these statements. Risks and uncertainties apply to them, and those are described in the Risk Factors section of our latest annual and quarterly SEC filings. What actually happens and what we actually report could differ materially from these forward-looking statements; we urge you to review the forward-looking statement disclaimer included in our earnings release as well as our quarterly and annual filings. Also, non-GAAP financial measures might be discussed today. For a reconciliation to the most comparable GAAP measures, please see our SEC filings and earnings supplement. In addition, time-sensitive information may be part of this conference call's content, and it is accurate only as of the date of this earnings call; no obligation to update or revise this information is undertaken or specifically disclaimed by us. I'll now hand the conference over to Mohit Marria, our CEO and Chief Investment Officer.
Mohit Marria
executiveModerator (Mohit Marria): Thanks, Vic. Morning, everybody, and thanks for joining us for the Chimera Investment Corporation call about the first quarter of 2022. Joining me today are our President and Chief Operating Officer, Choudhary Yarlagadda; our Chief Financial Officer, Subra Viswanathan; and Vic Falvo, who leads our Capital Markets. Subra will walk through the financial results after I speak, and then we'll take your questions. Beginning last year, we began preparing for a higher-rate environment by improving how our liabilities are structured, and as part of that push we re-securitized $6 billion in loans that had long-term fixed rate coupons. Once rates started climbing this year, we began putting into action the subsequent phase of our plan: buying high-yielding residential loans while still securing long-term financing via securitization. The sharp jump in headline inflation and the widening of credit spreads, both of which got underway late last year, carried on through the first quarter of 2022. The Federal Reserve Board started lifting short-term rates and said it would halt new purchases of agency mortgage-backed securities and might shrink its existing Treasury and MBS portfolios. The first quarter saw rapid market reactions to the Fed's statements: two-year Treasury notes rose 160 basis points, ten-year Treasury yields climbed 83 basis points, and 30-year mortgage rates increased by approximately 160 basis points. That combination of significant volatility and elevated interest rates affected our book value, which fell 14% over the quarter. Meanwhile, conditions allowed Chimera to expand its residential loan investment portfolio at yields considerably above what was obtainable in the prior year. We committed during this quarter to purchasing roughly $800 million in reperforming residential loans. We've put $570 million to rest in our loan warehouse, and the rest of those loans should be settled early in Q2. Thanks to fresh purchasing plus the closing of loans we bought late in 2021, we managed to settle close to $1 billion in loans during the period. These acquisitions ought to boost our earnings right away, and we'd like to bring in additional loans as rates keep climbing. February saw us sponsor CIM-2022-R1, marking our first securitization this year, backed by seasoned reperforming residential mortgage loans totaling $328 million in principal balance. Those loans carried an average coupon of 4.61% and have 169 months of seasoning. In a private placement, we sold securities from CIM-2022-R1 to institutional investors, with a total balance of roughly $264 million. Fitch and DBRS gave the senior securities a triple-A rating; they make up about 80% of the capital structure and carry a 3% fixed-rate coupon. We kept $64 million in subordinate notes and interest-only securities as investments for ourselves. Chimera also held onto an option allowing it to call the securitized mortgage loans at any point starting February 2027. With all the market volatility and rate increases we saw over this stretch, I'd like to take a moment to discuss the liability structure that we've put so much effort into establishing for our balance sheet. Securitization remains our primary way of funding mortgage assets. The debt involved is permanent, and call features were built in so we can fine-tune our liabilities over the long haul. When the quarter ended, securitized debt stood at $8.1 billion, representing 70% of the funding behind our mortgage assets. Of that securitized debt, $7.9 billion—98%—has fixed rate coupons. On March 31st, the weighted average rate on the $8.1 billion of securitized debt outstanding came to 2.5%. Repo or secured financing commitments account for the remaining 30% of our liabilities. As the quarter wrapped up, our secured financing agreements stood at $3.4 billion, amounting to merely a single turn of recourse leverage relative to our total capital. Within that $3.4 billion figure, $1.9 billion—equivalent to 56% of our secured financing—goes toward funding non-agency RMBS, which encompasses the retained securities we hold from securitizations. For this slice of our financing, the maturities are laddered, spanning from as short as one month all the way out to three years. Of that $1.9 billion, 64% was arranged under pricing structures for the underlying assets that are either non-mark-to-market or have limited mark-to-market features, while a mere 36% carries a mark-to-market pricing component linked to those underlying assets. The other $1.5 billion, representing 44% of our secured financing agreements, is allocated to funding our warehouse loans along with agency securities. On this piece of our financing, we've intentionally chosen a shorter duration. That gives us the most room to maneuver when it comes to securitizing our loans down the road and handling early prepayments we get on our Agency CMBS. At March 31st, the average rate across all $3.4 billion of our secured funding stood at 2.53%, a rise of 23 basis points compared with year end. Our assets continue to perform well, and in our view our liabilities are positioned favorably. At present, the company has a share repurchase plan in place that allows for buying back as much as 226 million of our common shares. Given that our stock's price has been swinging widely compared with our book value, we plan to weigh what buybacks could do for us against what other investments could add, with the goal of maximizing the long-term gain for our shareholders. In closing, across the last few years, we assembled a residential loan and securities portfolio with strong yields, funded mostly by way of securitization. For that portfolio, we secured fixed-rate funding at a low cost, and we routinely exercise call provisions to fine-tune our net interest spread. From the time the pandemic started, we have reworked our secured financing agreement so our portfolio stays protected when volatility runs high and markets are dislocated. Elevated rates on loans and broader credit spreads could give us a chance to expand the portfolio. A sizable buyback program is at our disposal, and we think we're set up nicely to continue squeezing the most dividend income possible for our investors over the long haul. At this point I'll pass it along to Subra, who will take us through the financial numbers for the quarter.
Subramaniam Viswanathan
executiveAppreciate that, Mohit. Let me cover Chimera's financial highlights for Q1 of 2022. Closing out Q1, our GAAP book value was $10.15 per share, while the economic return on that GAAP book value registered at -11.5% — a figure derived by taking the quarter-over-quarter change in book value and adding the dividend paid per common share during the first quarter. The GAAP net loss for the quarter amounted to $281 million, equal to $1.19 per share. On an earnings available for distribution basis, however, first-quarter net income came to $94 million, or $0.39 per share. Turning to one-time non-recurring items, we booked about $0.07 of income tied to securities that got called during the quarter. Economic net interest income for Q1 landed at $138 million. Looking at Q1, average interest earning assets produced a 6% yield. Funds cost us 2.3% on average, giving a net interest spread of 3.7%. Leverage totaled 3.5 to one for the first quarter, and recourse leverage ended the period at one to one. On an annualized basis, economic net interest return on average equity for the quarter was 15.6%, while GAAP return on average equity stood at -29.72%. Lastly, Q1 expenses came to $17 million once servicing fees and transaction expenses are excluded, down modestly versus a year earlier. That concludes what we wanted to share. We're ready to take your questions now.
Mike Smyth
analystHey, guys. Mike Smyth here, actually, filling in for Bose George. Just one thing on securitization markets. Could you offer some perspective on whether some of that older inventory has worked its way through? I'm curious if the pressure has started to moderate. And then as a follow-up, have loan prices moved at all to account for the wider spreads you're seeing in securitization?
Mohit Marria
executiveHey, good morning, Mike. Mohit here. Let me take the second question first, then I'll come back to the first. As I said during my opening remarks, mortgage spreads gapped out pretty substantially in Q1, and that by itself repriced loans regardless of what securitization was doing. On top of that, the securitization market made the effect worse because credit widening occurred alongside general market volatility. A lot of that overhang, if you mean newly originated product, was taken down, and deal issuance was quite significant compared with Q1 of 2021, even though rates were much lower then. I think the pull-through rates on where the production coupon was set shifted materially. Originators, and the issuers who purchase from them, brought a fair amount of non-QM and jumbo deals that no one expected. We flagged this on our Q4 earnings call as well, and that's where spread widening was most pronounced, and it also spilled over into part of the RPL space, where issuance represented a much smaller share of total new issue securitizations.
Mike Smyth
analystGreat. That's useful. Maybe just one on leverage. What level are you comfortable running that at? And what would you need to see in the market before you'd feel good about going on offense here?
Mohit Marria
executiveI mean, as we highlighted on the call, we have already gone on the offensive. We added $800+ million of new loans to the investment portfolio. Given the securitization volatility you just asked about, that's why we have completed only one securitization so far. As the market stabilizes, which appears to be happening here in Q2, we may bring more deals to market to term finance some of those loan acquisitions. Leverage did rise from 0.9 to one turn of recourse leverage for the quarter. Liquidity remains ample, with $1.5 billion in total that we look to deploy either into investments or, as I said, given the hit to our stock price relative to book value, we're going to assess on a relative value basis where the next dollar of investments should go. As for what the composition of the leverage could be, it depends on the asset types we buy. Our focus remains on credit assets, but with the widening that's occurred in agencies, if we buy more agencies, leverage would run a bit higher. If we stay more credit-focused, we would operate leverage around current levels to generate compelling returns. ROE will be the key factor in deciding where the next dollar of cash goes.
Mike Smyth
analystGreat. That's really helpful color. Just one more. Have you seen any movement in your book value so far in the second quarter?
Mohit Marria
executiveYeah. Given the continued move in rates, both on the belly of the curve and the 10-year, we project book value is down about 4%-5% since quarter end.
Mike Smyth
analystGreat. Thanks for taking the questions.
Mohit Marria
executiveThanks, Mike.
Trevor Cranston
analystHey, thanks. Good morning. You commented a bit on how loans are being repriced given the rise in interest rates and the widening in credit spreads. Could you walk through where RPLs are available for purchase today in terms of price and yield, and how ROE on new investment today compares with where it was at the end of last year? Thanks.
Mohit Marria
executiveSure. For most of last year, we were more focused on the liability side of the balance sheet, as we again noted in the earnings remarks. In the first half of last year, we actually purchased very little in new loans, but we were able to optimize deals issued in prior years to lock in lower-rate financing. During the second half of the year, we had more success acquiring loans. Given the low all-in yields at the time, whether seasoned re-performing, non-QM, or prime jumbo, loans were trading on a spread basis of swaps plus mid-100s. That number has now widened to perhaps swaps plus 200, but the increase in all-in rates has pushed loan yields to something like mid-high fours today. As I said, the securitization market hasn't missed that effect, so demand to execute a securitization has also risen. Based on where you could sell the top of the capital structure, retained pieces are probably yielding low double digits right now.
Trevor Cranston
analystOkay, got it. That's helpful.
Mohit Marria
executiveThe last thing.
Trevor Cranston
analystIn terms of.
Mohit Marria
executiveThe last thing I will say.
Trevor Cranston
analystOh, go ahead. Sorry.
Mohit Marria
executiveLet me just make one last comment. The loan market, at least on the seasoned re-performing side, isn't something being produced; it already exists. On average, these loans are 100 months-160 months seasoned, depending on what comes up for sale. The controlled nature of that flow has protected against some of the spread widening seen in newer origination products. Yesterday, Fannie Mae held their second loan sale of the year, and based on early color, it appears to have traded well and in line with the spreads I just mentioned to you.
Trevor Cranston
analystOkay, got it. That's good color. Regarding the book value change, could you roughly break down how much came from rate movement versus credit spread movement? And is there any sort of net duration exposure on the portfolio at this point? Thanks.
Mohit Marria
executiveSure. A lot of the book value movement is a function of rates. As I said, the belly of the curve moved about 165 to 170 basis points from December through March. The ten-year itself moved over 80+ basis points over that same timeframe. That led to a large movement in our book value. From a credit perspective, spreads were wider in sympathy with what happened to agencies. I would attribute about 25% of the book value reduction to that. 75% of the change was driven by the rate movement. And as we move past quarter end, rates have continued to sell off.
Trevor Cranston
analystSo look, the 10-year and the 5-year have both shifted. On the 5-year, roughly 35% of that move, I believe, happened during Q1, while nearly 70% of what we've seen on the 10-year so far has come in April. That's the reason book value, again, has dropped somewhere in the 4%-5% range since quarter-end. Yesterday the Fed made an announcement, and I think it brought a bit more clarity about what they're going to do. There was plenty of talk about a possible 75 basis point hike, but Powell has basically ruled that out. He's anticipating a couple of 50 basis point hikes — possibly two, perhaps three — and then they'll evaluate whatever the data shows about inflation expectations. That, I believe, has provided a bit more clarity on where rates are headed as we move into the second half of the year. Great, understood. Thanks for that comment. Appreciate it.
Doug Harter
analystThank you. In the past, you've been effective at calling and reissuing securitizations to strengthen your liability structure. Clearly, the expense associated with doing so has risen. Could you discuss whether there's still a chance to achieve that and obtain the releverage advantage, or whether alternative approaches exist to relever those securitizations?
Mohit Marria
executiveThat's a solid question. During our Q4 earnings call, we pointed out that we hold a considerable number of deals that either are callable now or will become callable during calendar year 2022, and our supplement includes a page showing this. As you noted, the expense of issuing new debt has risen substantially between Q4 and the present. When we weigh the equity takeout from those deals and redeploying it now against issuing new debt, we're keeping a constant watch on the situation. Right now, doing that just isn't very appealing. The fresh debt we'd have to take on would basically cancel out any benefit from putting that equity to work, even if we used it to buy back stock. We'll keep looking at this as the year goes on. Here's another angle: every month those deals stay on the books, as they get paid down and keep deleveraging, that gives us one more dollar of equity we can pull out later, once we decide to call those deals. Going forward, it's a source of liquidity for the company.
Doug Harter
analystI'm wondering if there's a way to borrow against the extra equity that keeps accumulating, rather than going through the entire securitization process again and losing those favorable funding costs.
Mohit Marria
executiveAbsolutely. As the junior tranches we retain from those deals continue to amortize, our repo counterparties would take that into account, and gradually we could extract additional value from those assets by increasing what we borrow against them via repo — that gives us another path to reach that equity.
Doug Harter
analystUnderstood. That market has certainly had its share of volatility, I'd imagine. How would you describe the market there and how comfortable you are, given how volatile that kind of financing is?
Mohit Marria
executiveYeah. I think if you look at the repo market overall in Q1, with the big rate move and the geopolitical events happening, the market has actually held up quite well. Particularly, as I said, with yesterday's Fed announcement, there's a bit more clarity now on where rates might go; as of today, we don't really see a problem there. Again, given the liquidity we hold in the company and what our cash needs are right now, if we're comfortable and we spot attractive opportunities, we'll take on more leverage and put additional assets on repo. As we've noted before, we're very deliberate about the type of financing we bring in. Ideally, we'd go with longer-dated, non-mark-to-market arrangements, though we need to weigh that against the price of such financing relative to the opportunities we have to invest. All things considered, we feel pretty good about the current state of the repo market and the counterparties we deal with.
Doug Harter
analystExcellent. Appreciate it.
Mohit Marria
executiveThanks, Doug.
Mohit Marria
executiveThank you, operator, and thanks to all of you for being with us today — we're looking forward to talking with you again on our Q2 earnings call.
Operator
operatorAppreciate it. That brings us to the end of today's call, and we're grateful you joined us. At this point you're welcome to hang up, and we hope the rest of your day goes well.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.